INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.870
+0.040 (2.19%)
At close: Oct 14, 2025, 4:00 PM EDT
1.860
-0.010 (-0.53%)
After-hours: Oct 14, 2025, 7:51 PM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $49.71 million as of October 14, 2025. Its market cap has decreased by -54.64% in one year.
Market Cap
49.71M
Enterprise Value
16.79M
1-Year Change
-54.64%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $49.71M, a decrease of -36.12%. That is a compound annual growth rate of -6.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 48.65M | -53.01% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | 231.57M | 270.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |